Navigation Links
Morphotek Enters Into Agreements With Fox Chase Cancer Center to Acquire Clinical Samples for the Development and Validation of Companion Diagnostic Kits
Date:1/10/2012

etuzumab, which is currently being tested in several clinical trials against different types of cancers, including non-small cell lung adenocarcinoma and ovarian carcinoma.  Studies have found expression levels to be variable between different cancer types. In light of this variability, a diagnostic assay that can identify patients with FRA-positive cancers may enable better diagnosis and treatment of patients affected with FRA-expressing cancers.

"We are excited to enter into these agreements with Fox Chase for a number of reasons: They are a local organization based in Philadelphia, one of the leading cancer research and treatment centers in the United States and a designated National Cancer Institute Comprehensive Cancer Center.
Fox Chase is a highly reputable organization with a well organized biorepository containing a bank of well-annotated samples from a variety of cancer  types and the appropriate procedures and people in place to allow prospective studies and data management to take place," stated Dan O'Shannessy, PhD, Director Diagnostic Development at Morphotek.  "We believe that with today's technology, the success or failure of a companion diagnostics program is governed by the quality of samples available for analysis.  The initiation of this project will be a significant step forward for our therapeutic development programs.  Furthermore, it supports our human health care (hhc) mission by better defining a patient's disease subtype to help design more appropriate therapeutic regimens."

"Fox Chase is enthusiastic about collaborating with Morphotek to advance diagnostic applications in the growing field of personalized medicine for oncology therapies," says Kurt A. Schwinghammer, Ph.D., Vice President of Research and Development Alliances at Fox Chase Cancer Center. "We wholeheartedly support Morphotek's initiative to develop diagnostic assays to help determine which patients will best respond to t
'/>"/>

SOURCE Morphotek, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Morphotek®, Inc. Announces Initiation of Farletuzumab Phase II Study in First-Line Treatment of Non-Small Cell Lung Cancer
2. Morphotek, Inc. Announces That Two Investigational Drugs Have Received Orphan Drug Designations
3. Morphotek®, Inc. Announces Acquisition of Tumor Targeting Assets From Transmolecular, Inc.
4. MacuCLEAR, Inc. Raises More Than $1M in Financing and Enters into Strategic Pacific Rim Partnership
5. Medical Centers Worldwide Adopt Both Accurays CyberKnife and TomoTherapy Systems
6. Dehaier Medical Enters European Homecare Medical Product Market
7. Molecular Imaging, Inc. Enters Relationship with Dana-Farber Cancer Institute to Expand Luciferase-reporter Cancer Cell Lines for Preclinical in vivo Imaging
8. Vanda Pharmaceuticals Enters into an Exclusive License Agreement with Megapharm Ltd. for Commercialization of Fanapt™ in Israel
9. HeartSine® Technologies Now Exclusive Provider of Lifesaving AEDs to Golden LivingCenters
10. CIVCO Enters CT Needle Guidance Market with RAD-GUIDE™ Launch
11. Innocoll Enters Partnership with Merus Labs in Canada for the Distribution of CollaGUARD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... 28, 2015  The recent flurry of PBM ... employer groups scrambling to identify a pharmacy benefit ... care plan, retail pharmacy chain, or other potentially ... purchase of Catamaran, Rite Aid,s $2 billion acquisition ... Omni-Care for $10 billion are just the latest ...
(Date:5/28/2015)... , May 28, 2015 The ... the Commission,s antitrust suit charging Cephalon, Inc. with ... drug Provigil. The settlement ensures that Teva Pharmaceutical ... make a total of $1.2 billion available to ... who overpaid because of Cephalon,s illegal conduct.  ...
(Date:5/28/2015)... BURNABY, British Columbia , May 28, 2015 ... company developing an intravenous catheter-based phrenic-nerve-pacing system announced ... Jefferies 2015 Global Healthcare Conference on Thursday, June ... PE will present at 11:30 a.m. Eastern Time.   ... Lungpacer Medical is a preclinical stage medical ...
Breaking Medicine Technology:Citizens Rx Addresses Recent PBM Consolidation and Rising Pharmacy Costs 2Citizens Rx Addresses Recent PBM Consolidation and Rising Pharmacy Costs 3FTC Settlement of Cephalon Pay for Delay Case Ensures $1.2 Billion in Ill-Gotten Gains Relinquished; Refunds Will Go To Purchasers Affected By Anticompetitive Tactics 2FTC Settlement of Cephalon Pay for Delay Case Ensures $1.2 Billion in Ill-Gotten Gains Relinquished; Refunds Will Go To Purchasers Affected By Anticompetitive Tactics 3
... new and innovative technology has enabled more and more ... office, the central laboratory is hardly threatened with extinction. ... are busier than ever before, and the huge range ... handle very large volumes of tests assures them an ...
... ,Contributing Editor , ,Appendicitis is a common, potentially ... their lives. The condition occurs when the appendix, ... becomes obstructed by mucus, stool, or lymphatic tissue. ... sepsis. The risk of these complications, already elevated ...
Cached Medicine Technology:Immunoassay Systems - Your Laboratory Workhorse 2Appendicitis: Evolving Tools to Diagnose a Classic Disease 2Appendicitis: Evolving Tools to Diagnose a Classic Disease 3
(Date:5/28/2015)... Baptist Medical Center Jacksonville has added ... acute stroke or other neurological conditions. , The new ... few in the country and the first in Florida ... as brain aneurysms. , “Baptist Health is committed ... who are impacted by stroke,” said Nicole Thomas, Baptist ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 Real Time ... lotion and products, today announced their best-selling lotion is now ... Time Pain Relief is an FDA registered OTC pain relief ... herbal ingredients, such as Aloe Vera, Arnica, Capsicum, Chondroitin, Emu ... level of Menthol – only 1.25% – to avoid buildup ...
(Date:5/28/2015)... Hills, CA (PRWEB) May 28, 2015 ... novel interactive keratoconus web application to make ... has expanded in the last few years. This proliferation ... eye doctors are not aware of the nuances of ... Khanna Vision Institute, realized that websites can be boring ...
(Date:5/28/2015)... Optimity Advisors ( Optimity ) – ... care for healthcare organizations worldwide – today announced ... operationalize contracting and engagement models. As part of ... of seven “ OrangePapers” that provide actionable ... a strategy, operations and information technology advisory firm ...
(Date:5/28/2015)... 28, 2015 The drug epidemic has struck ... article published on May 12th, 2015, by Bradenton , ... of time. The first victim, Dylan Besser (21) was a ... the scene. The second overdose victim, Julian Toomsen-Hall (18) was ... the alarming overdose deaths on campus, the college has created ...
Breaking Medicine News(10 mins):Health News:Baptist Medical Center Jacksonville Adds Dedicated Neuro Emergency Unit 2Health News:Baptist Medical Center Jacksonville Adds Dedicated Neuro Emergency Unit 3Health News:Real Time Pain Relief Introduces New Four Ounce Pump Bottle for their Popular Pain Relief Lotion 2Health News:Dr.Khanna Announced the Release of an Interactive Web Application for Keratoconus Treatment 2Health News:Optimity Advisors Now Offers Outcomes Based Contracting Services to Support Engagement Model For New Healthcare Innovative Models of Care 2Health News:Two College Campus Deaths Force Sarasota College to Create Drug Task Force 2Health News:Two College Campus Deaths Force Sarasota College to Create Drug Task Force 3
... at Buffalo,s Research Institute on Addictions (RIA) is initiating ... used in behavioral medicine for stress reduction but not ... use disorders. , ... MBSR in alcoholism treatment, we hope to develop an ...
... testing company to license proprietary ... ... DGX ), the nation,s leading provider of diagnostic,testing, information and ... agreement for the heteroduplex tracking technology,underlying Pathway Diagnostics, SensiTrop(TM) HIV co-receptor ...
... care the hard way -- when they or a loved one needs ... term care is expensive; -- It is not covered under Medicare, ... and -- Medicaid will only pay for your long term care ... assets. Even then, Medicaid is heavily biased toward ...
... Fla., Oct. 26 In an effort to raise,awareness ... of U.S. News,& World Report will feature a cover ... a ranking of the nations, top 50 commercial,health plans, ... nations, best Medicare and,Medicaid plans. All the rankings are ...
... on anti-aging and ... personal beauty, ... launch of the first consumer website dedicated,to consumer reviews and expert ... in an,open and honest conversation about important decisions that affect the ...
... Oct. 26, 2007 11:00AM Adults with ... OROS methylphenidate HCl Extended-release Tablets showed significant improvements ... placebo, according to study results presented today at ... of children and adolescents with ADHD is clearly ...
Cached Medicine News:Health News:Dealing with stress as a treatment for alcohol abuse 2Health News:Quest Diagnostics Licenses Technology Underlying SensiTrop(TM) HIV Co-Receptor Tropism Test from Pathway Diagnostics 2Health News:Quest Diagnostics Licenses Technology Underlying SensiTrop(TM) HIV Co-Receptor Tropism Test from Pathway Diagnostics 3Health News:Quest Diagnostics Licenses Technology Underlying SensiTrop(TM) HIV Co-Receptor Tropism Test from Pathway Diagnostics 4Health News:Congress Declares 'Long Term Care Awareness Week' - Long Term Care Group, Inc. Continues Related Work 2Health News:Blue Cross and Blue Shield of Florida NCQA/U.S. News & World Report Ranking 2Health News:Consumers Open Up on RealSelf.com About 'Getting Work Done' 2Health News:Consumers Open Up on RealSelf.com About 'Getting Work Done' 3Health News:New study of Concerta showed significant improvement of ADHD symptom management in adults 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: